80 results on '"Thakar CV"'
Search Results
2. Predicting acute kidney injury after cardiac surgery: how to use the 'crystal ball'.
- Author
-
Thakar CV
- Published
- 2010
- Full Text
- View/download PDF
3. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies.
- Author
-
Nigwekar SU, Kandula P, Hix JK, and Thakar CV
- Abstract
BACKGROUND: Acute kidney injury (AKI) after coronary artery bypass grafting (CABG) is associated with significant morbidity and mortality. Controversy exists regarding whether an off-pump technique can reduce post-CABG renal injury. STUDY DESIGN: Systematic review and meta-analysis. SETTING & POPULATION: Adult patients undergoing CABG. SELECTION CRITERIA FOR STUDIES: MEDLINE, EMBASE, Cochrane Renal Library, and Google Scholar were searched in May 2008 for randomized controlled trials (RCTs) and observational studies comparing off-pump CABG (OPCAB) with conventional CABG (CAB) for renal outcomes. Studies involving patients on long-term renal replacement therapy (RRT) were excluded. INTERVENTION: OPCAB. OUTCOMES: Primary outcomes were overall AKI and AKI requiring RRT. RESULTS: 22 studies (6 RCTs and 16 observational studies) comprising 27,806 patients met the inclusion criteria. The pooled effect from both study cohorts showed a significant reduction in overall AKI (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.43 to 0.76; P for effect < 0.001; I(2) = 67%; P for heterogeneity < 0.001) and AKI requiring RRT (OR, 0.55; 95% CI, 0.43 to 0.71; P for effect < 0.001; I(2) = 0%; P for heterogeneity = 0.5) in the OPCAB group compared with the CAB group. In RCTs, overall AKI was significantly reduced in the OPCAB group (OR, 0.27; 95% CI, 0.13 to 0.54); however, no statistically significant difference was noted in AKI requiring RRT (OR, 0.31; 95% CI, 0.06 to 1.59). In the observational cohort, both overall AKI (OR, 0.61; 95% CI, 0.45 to 0.81) and AKI requiring RRT (OR, 0.54; 95% CI, 0.40 to 0.73) were significantly less in the OPCAB group. RCTs were noted to be underpowered and biased toward recruiting low-risk patients. Sensitivity analysis restricted to good-quality studies showed a significant reduction in AKI. LIMITATIONS: Lack of uniform AKI definition in the included studies, heterogeneity for overall AKI outcome. CONCLUSIONS: Analysis of the current evidence suggests a reduction in AKI using the OPCAB technique; however, studies lack consistency in defining AKI. Available RCTs are underpowered to detect a difference in AKI requiring RRT; evidence from observational studies suggests a reduction in RRT requirement. Future studies should apply a standard definition of AKI and target a high-risk population. Copyright © 2009 National Kidney Foundation, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
4. Improved survival in acute kidney injury after cardiac surgery.
- Author
-
Thakar CV, Worley S, Arrigain S, Yared JP, and Paganini EP
- Abstract
BACKGROUND: The overall incidence of acute kidney injury (AKI) or mortality after cardiac surgery is low, but mortality in patients with AKI remains high. Effects of factors such as change in comorbid disease burden, intraoperative factors, or postoperative complications on trends in the incidence of AKI and associated mortality after cardiac surgery were not examined. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 34,562 cardiac surgeries were performed from 1993 to 2002; only the first surgical procedure was considered (N = 33,217). PREDICTOR, OUTCOMES, & MEASUREMENTS: AKI was defined as a composite outcome of a 50% or greater decrease in postoperative glomerular filtration rate or requirement of dialysis (AKI-D). Mortality was defined as postoperative hospital mortality. We examined effects of the predictors AKI and year of surgery on mortality after accounting for preoperative risk factors and serious postoperative complications. RESULTS: Between the first and second halves of the study period (1993 to 2002), the incidence of AKI increased from 5.1% to 6.6%, but the associated mortality rate decreased from 32% to 23% (P < 0.0001). Similarly, the incidence of AKI-D also increased from 1.5% to 2.0%, with a decrease in associated mortality from 61% to 49% (P < 0.01). In a risk-adjusted model, mortality in patients with AKI significantly decreased over time. Patients with AKI-D and with other organ system failures did not show improvement in survival over time. A preoperative history of congestive heart failure was associated significantly with a decrease in mortality risk over time, particularly in patients requiring dialysis. LIMITATIONS: Single-center, retrospective, observational cohort design. CONCLUSION: The incidence of AKI after cardiac surgery has increased over time. Although the adjusted risk of mortality decreased in patients with AKI without other postoperative complications, it is unchanged in those with multiorgan system failure. Copyright © 2007 by Elsevier Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
5. Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality.
- Author
-
Hix JK, Thakar CV, Katz EM, Yared J, Sabik J, and Paganini EP
- Abstract
OBJECTIVE: Risk of mortality after cardiac surgery is associated with severity of acute kidney injury. The aim of this study is to examine the effect of off-pump coronary artery bypass surgery on the risk of postoperative acute kidney injury and its association with mortality. DESIGN: Observational cohort study. SETTING: Tertiary care center. PATIENTS: Some 10,061 patients underwent coronary artery bypass surgery (1998-2002), of which 1,365 patients underwent off-pump surgery. INTERVENTIONS: Acute kidney injury was defined as either requirement of dialysis or >/=50% decline in postoperative glomerular filtration rate but not requiring dialysis. We compared on- and off-pump surgeries and used propensity score matching to examine the effect of off-pump surgery on acute kidney injury and mortality. MEASUREMENTS AND MAIN RESULTS: We found that 2.6% on-pump and 1.2% off-pump patients developed acute kidney injury requiring dialysis among the 2,370 matched subjects (relative risk, 2.06; 95% confidence interval [CI], 1.36-3.36); 5.0% of on-pump patients suffered a >/=50% decline in glomerular filtration rate compared with 2.5% in off-pump group (relative risk, 2.00; 95% CI, 1.48-2.82). The mortality rate in the matched cohort was 2.3% for on-pump group vs. 0.6% in off-pump group (relative risk, 3.88; 95% CI, 2.29-9.50). Among matched patients with acute kidney injury, the risk of mortality was 13.14 (95% CI, 8.43-30.50) in patients requiring dialysis and 9.33 (95% CI, 4.83-19.00) in those with >/=50% decline in glomerular filtration rate but not requiring dialysis. CONCLUSIONS: Off-pump surgery is associated with a lower risk of developing acute kidney injury (regardless of its definition). The risk of mortality is incremental with worsening degrees of acute kidney injury. Lower risk of acute kidney injury may be one of the factors that offer a survival advantage after off-pump surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
6. Sex Differences in Cardiovascular Outcomes in Patients With Kidney Failure.
- Author
-
Shah S, Christianson AL, Meganathan K, Leonard AC, Crews DC, Rubinstein J, Mitsnefes MM, Schauer DP, and Thakar CV
- Subjects
- Humans, Female, Male, Aged, Sex Factors, United States epidemiology, Aged, 80 and over, Middle Aged, Heart Failure mortality, Heart Failure epidemiology, Risk Factors, Renal Dialysis, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Kidney Failure, Chronic epidemiology, Kidney Failure, Chronic complications, Risk Assessment methods, Hospitalization statistics & numerical data, Retrospective Studies, Medicare statistics & numerical data, Stroke epidemiology, Stroke mortality, Time Factors, Acute Coronary Syndrome mortality, Acute Coronary Syndrome epidemiology, Acute Coronary Syndrome therapy, Acute Coronary Syndrome complications, Renal Insufficiency epidemiology, Renal Insufficiency mortality, Cardiovascular Diseases mortality, Cardiovascular Diseases epidemiology, Cause of Death
- Abstract
Background: Cardiovascular disease is the leading cause of mortality in patients with kidney failure, and their risk of cardiovascular events is 10 to 20 times higher as compared with the general population., Methods and Results: We evaluated 508 822 patients who initiated dialysis between January 1, 2005 and December 31, 2014 using the United States Renal Data System with linked Medicare claims. We determined hospitalization rates for cardiovascular events, defined by acute coronary syndrome, heart failure, and stroke. We examined the association of sex with outcome of cardiovascular events, cardiovascular death, and all-cause death using adjusted time-to-event models. The mean age was 70±12 years and 44.7% were women. The cardiovascular event rate was 232 per thousand person-years (95% CI, 231-233), with a higher rate in women than in men (248 per thousand person-years [95% CI, 247-250] versus 219 per thousand person-years [95% CI, 217-220]). Women had a 14% higher risk of cardiovascular events than men (hazard ratio [HR], 1.14 [95% CI, 1.13-1.16]). Women had a 16% higher risk of heart failure (HR, 1.16 [95% CI, 1.15-1.18]), a 31% higher risk of stroke (HR, 1.31 [95% CI, 1.28-1.34]), and no difference in risk of acute coronary syndrome (HR, 1.01 [95% CI, 0.99-1.03]). Women had a lower risk of cardiovascular death (HR, 0.89 [95% CI, 0.88-0.90]) and a lower risk of all-cause death than men (HR, 0.96 [95% CI, 0.95-0.97])., Conclusions: Among patients undergoing dialysis, women have a higher risk of cardiovascular events of heart failure and stroke than men. Women have a lower adjusted risk of cardiovascular mortality and all-cause mortality.
- Published
- 2024
- Full Text
- View/download PDF
7. A clinical score to predict recovery in end-stage kidney disease due to acute kidney injury.
- Author
-
Shah S, Ng JH, Leonard AC, Harrison K, Meganathan K, Christianson AL, and Thakar CV
- Abstract
Background: Acute kidney injury (AKI) is a major contributor to end-stage kidney disease (ESKD). About one-third of patients with ESKD due to AKI recover kidney function. However, the inability to accurately predict recovery leads to improper triage of clinical monitoring and impacts the quality of care in ESKD., Methods: Using data from the United States Renal Data System from 2005 to 2014 ( n = 22 922), we developed a clinical score to predict kidney recovery within 90 days and within 12 months after dialysis initiation in patients with ESKD due to AKI. Multivariable logistic regressions were used to examine the effect of various covariates on the primary outcome of kidney recovery to develop the scoring system. The resulting logistic parameter estimates were transformed into integer point totals by doubling and rounding the estimates. Internal validation was performed., Results: Twenty-four percent and 34% of patients with ESKD due to AKI recovered kidney function within 90 days and 12 months, respectively. Factors contributing to points in the two scoring systems were similar but not identical, and included age, race/ethnicity, body mass index, congestive heart failure, cancer, amputation, functional status, hemoglobin and prior nephrology care. Three score categories of increasing recovery were formed: low score (0-6), medium score (7-9) and high score (10-12), which exhibited 90-day recovery rates of 12%, 26% and 57%. For the 12-month scores, the low, medium and high groups consisted of scores 0-5, 6-8 and 9-11, with 12-month recovery rates of 16%, 33% and 62%, respectively. The internal validation assessment showed no overfitting of the models., Conclusion: A clinical score derived from information available at incident dialysis predicts renal recovery at 90 days and 12 months in patients with presumed ESKD due to AKI. The score can help triage appropriate monitoring to facilitate recovery and begin planning long-term dialysis care for others., Competing Interests: J.H.N. received consultancy fees from Vifor Pharmaceuticals and George Clinicals. She is the founder of PublishedMD Consulting LLC. The remaining authors have no disclosures and competing interests. The results presented in this paper have not been published previously in whole or part, except in abstract format. The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government., (© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.)
- Published
- 2024
- Full Text
- View/download PDF
8. Cardiovascular Outcomes in Patients on Home Hemodialysis and Peritoneal Dialysis.
- Author
-
Shah S, Weinhandl E, Gupta N, Leonard AC, Christianson AL, and Thakar CV
- Subjects
- Humans, Cohort Studies, Hemodialysis, Home, Peritoneal Dialysis adverse effects
- Published
- 2024
- Full Text
- View/download PDF
9. An Engaged and Empowered Patient: A Critically Important Concept in Nephrology.
- Author
-
Nigwekar SU and Thakar CV
- Subjects
- Renal Dialysis, Nephrology
- Published
- 2024
- Full Text
- View/download PDF
10. Definition, Staging, and Role of Biomarkers in Acute Kidney Injury in the Context of Cardiovascular Interventions.
- Author
-
Gudsoorkar PS, Nysather J, and Thakar CV
- Subjects
- Humans, Biomarkers blood, Creatinine blood, Severity of Illness Index, Acute Kidney Injury blood, Acute Kidney Injury diagnosis, Cardiovascular Surgical Procedures adverse effects, Terminology as Topic
- Abstract
Acute kidney injury (AKI) is a frequently occurring complication of cardiovascular interventions, and associated with adverse outcomes. Therefore, a clear definition of AKI is of paramount importance to enable timely recognition and treatment. Historically, changes in the serum creatinine and urine output have been used to define AKI, and the criteria have evolved over time with better understanding of the impact of AKI on the outcomes. However, the reliance on serum creatinine for these AKI definitions carries numerous limitations including delayed rise, inability to differentiate between hemodynamics versus structural injury and assay variability to name a few., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
11. Social determinants of patiromer adherence and abandonment: An observational, retrospective, real-world claims analysis.
- Author
-
Kleinman N, Kammerer J, LaGuerre K, and Thakar CV
- Subjects
- Male, Adult, Humans, Aged, United States, Retrospective Studies, Insurance Claim Review, Social Determinants of Health, Medicare, Medication Adherence, Hyperkalemia drug therapy, Hyperkalemia epidemiology, Hyperkalemia complications, Heart Failure complications, Heart Failure drug therapy, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic drug therapy
- Abstract
Background: Hyperkalemia is a frequent and serious complication in chronic kidney disease (CKD) that can impede continuation of beneficial evidence-based therapies. Recently, novel therapies such as patiromer have been developed to treat chronic hyperkalemia, but their optimal utility hinges on adherence. Social determinants of health (SDOH) are critically important and can impact both medical conditions and treatment prescription adherence. This analysis examines SDOH and their influence on adherence to patiromer or abandonment of prescriptions for hyperkalemia treatment., Methods: This was an observational, retrospective, real-world claims analysis of adults with patiromer prescriptions and 6- and 12-months pre- and post-index prescription data in Symphony Health's Dataverse during 2015-2020, and SDOH from census data. Subgroups included patients with heart failure (HF), hyperkalemia-confounding prescriptions, and any CKD stages. Adherence was defined as >80% of proportion of days covered (PDC) for ≥60 days and ≥6 months, and abandonment as a portion of reversed claims. Quasi-Poisson regression modeled the impact of independent variables on PDC. Abandonment models used logistic regression, controlling for similar factors and initial days' supply. Statistical significance was p<0.05., Results: 48% of patients at 60 days and 25% at 6 months had a patiromer PDC >80%. Higher PDC was associated with older age, males, Medicare/Medicaid coverage, nephrologist prescribed, and those receiving renin-angiotensin-aldosterone system inhibitors. Lower PDC correlated with higher out-of-pocket cost, unemployment, poverty, disability, and any CKD stage with comorbid HF. PDC was better in regions with higher education and income., Conclusions: SDOH (unemployment, poverty, education, income) and health indicators (disability, comorbid CKD, HF) were associated with low PDC. Prescription abandonment was higher in patients with prescribed higher dose, higher out-of-pocket costs, those with disability, or designated White. Key demographic, social, and other factors play a role in drug adherence when treating life-threatening abnormalities such as hyperkalemia and may influence patient outcomes., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: This study was funded by CSL Vifor, a commercial pharmaceutical company that manufactures a medication to treat hyperkalemia (URL: https://www.viforpharma.com/us). NK reports consulting for CSL Vifor, Ceresti Health, Twin Health, Taproot Health, GNS Healthcare, and HCMS. JK reports employment by and stock in CSL Vifor. KL reports previous employment by CSL Vifor at the time of the study. CVT reports consulting for CSL Vifor, Fresenius-NxStage, and National Kidney Foundation, and honoraria from Teladoc. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare., (Copyright: © 2023 Kleinman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
12. Sex and Racial/Ethnic Differences in Home Hemodialysis Mortality.
- Author
-
Shah S, Gupta N, Christianson AL, Meganathan K, Leonard AC, and Thakar CV
- Subjects
- Humans, Ethnicity, Hemodialysis, Home mortality
- Published
- 2023
- Full Text
- View/download PDF
13. Advances in Kidney Disease and Health: It's all in the Name.
- Author
-
Thakar CV
- Subjects
- Humans, Kidney Diseases diagnosis, Names
- Published
- 2023
- Full Text
- View/download PDF
14. Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions.
- Author
-
Prasad A, Palevsky PM, Bansal S, Chertow GM, Kaufman J, Kashani K, Kim ESH, Sridharan L, Amin AP, Bangalore S, Briguori C, Charytan DM, Eng M, Jneid H, Brown JR, Mehran R, Sarnak MJ, Solomon R, Thakar CV, Fowler K, and Weisbord S
- Abstract
Patients with chronic kidney disease (CKD) are at an increased risk of developing cardiovascular disease (CVD), whereas those with established CVD are at risk of incident or progressive CKD. Compared with individuals with normal or near normal kidney function, there are fewer data to guide the management of patients with CVD and CKD. As a joint effort between the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions, a workshop and subsequent review of the published literature was held. The present document summarizes the best practice recommendations of the working group and highlights areas for further investigation.
- Published
- 2022
- Full Text
- View/download PDF
15. Implementing a Health Utility Assessment Platform to Acquire Health Utilities in a Hemodialysis Outpatient Setting: Feasibility Study.
- Author
-
Adejare AA, Duncan HJ, Motz RG, Shah S, Thakar CV, and Eckman MH
- Abstract
Background: Patients with end-stage kidney disease (ESKD) wait roughly 4 years for a kidney transplant. A potential way to reduce wait times is using hepatitis C virus (HCV)-viremic kidneys., Objective: As preparation for developing a shared decision-making tool to assist patients with ESKD with the decision to accept an HCV-viremic kidney transplant, our initial goal was to assess the feasibility of using The Gambler II, a health utility assessment tool, in an ambulatory dialysis clinic setting. Our secondary goals were to collect health utilities for patients with ESKD and to explore whether the use of race-matched versus race-mismatched exemplars impacted the knowledge gained during the assessment process., Methods: We used The Gambler II to elicit utilities for the following ESKD-related health states: hemodialysis, kidney transplant with HCV-unexposed kidney, and transplantation with HCV-viremic kidney. We created race exemplar video clips describing these health states and randomly assigned patients into the race-matched or race-mismatched video arms. We obtained utilities for these 3 health states from each patient, and we evaluated knowledge about ESKD and HCV-associated health conditions with pre- and postintervention knowledge assessments., Results: A total of 63 patients with hemodialysis from 4 outpatient Dialysis Center Inc sites completed the study. Mean adjusted standard gamble utilities for hemodialysis, transplant with HCV-unexposed kidney, and transplantation with HCV-viremic kidney were 82.5, 89, and 75.5, respectively. General group knowledge assessment scores improved by 10 points (P<.05) following utility assessment process. The use of race-matched exemplars had little effect on the results of the knowledge assessment of patients., Conclusions: Using The Gambler II to collect utilities for patients with ESKD in an ambulatory dialysis clinic setting proved feasible. In addition, educational information about health states provided as part of the utility assessment process tool improved patients' knowledge and understanding about ESKD-related health states and implications of organ transplantation with HCV-viremic kidneys. A wide variation in patient health state utilities reinforces the importance of incorporating patients' preferences into decisions regarding use of HCV-viremic kidneys for transplantation., (©Adeboye A Adejare, Heather J Duncan, R Geoffrey Motz, Silvi Shah, Charuhas V Thakar, Mark H Eckman. Originally published in JMIR Formative Research (https://formative.jmir.org), 28.07.2022.)
- Published
- 2022
- Full Text
- View/download PDF
16. Kidney Disease Care and Policy: An Ongoing Affair.
- Author
-
Thakar CV
- Subjects
- Humans, Kidney Diseases, Policy
- Published
- 2022
- Full Text
- View/download PDF
17. Incorporating Patients' Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study.
- Author
-
Eckman MH, Adejare AA, Duncan H, Woodle ES, Thakar CV, Alloway RR, and Sherman KE
- Abstract
Introduction. While use of (hepatitis C virus) HCV-viremic kidneys may result in net benefit for the average end-stage kidney disease (ESKD) patient awaiting transplantation, patients may have different values for ESKD-related health states. Thus, the best decision for any individual may be different depending on the balance of these factors. Our objective was to explore the feasibility of sampling health utilities from hemodialysis patients in order to perform patient-specific decision analyses considering various transplantation strategies. Study Design. We assessed utilities on a convenience sample of hemodialysis patients for health states including hemodialysis, and transplantation with either an HCV-uninfected kidney or an HCV-viremic kidney. We performed patient-specific decision analyses using each patient's age, race, gender, dialysis vintage, and utilities. We used a Markov state transition model considering strategies of continuing hemodialysis, transplantation with an HCV-unexposed kidney, and transplantation with an HCV-viremic kidney and HCV treatment. We interviewed 63 ESKD patients from four dialysis centers (Dialysis Clinic Inc., DCI) in the Cincinnati metropolitan area. Results. Utilities for ESKD-related health states varied widely from patient to patient. Mean values were highest for -transplantation with an HCV-uninfected kidney (0.89, SD: 0.18), and were 0.825 (SD: 0.231) and 0.755 (SD: 0.282), respectively, for hemodialysis and transplantation with an HCV-viremic kidney. Patient-specific decision analyses indicated 37 (59%) of the 63 ESKD patients in the cohort would have a net gain in quality-adjusted life years from transplantation of an HCV-viremic kidney, while 26 would have a net loss. Conclusions. It is feasible to gather dialysis patients' health state utilities and perform personalized decision analyses. This approach could be used in the future to guide shared decision-making discussions about transplantation strategies for ESKD patients., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2021.)
- Published
- 2021
- Full Text
- View/download PDF
18. Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons.
- Author
-
Thakar CV
- Subjects
- Disease Progression, Humans, Diabetes Mellitus, Diabetic Nephropathies therapy, Kidney Failure, Chronic
- Published
- 2021
- Full Text
- View/download PDF
19. Dialysis: Please Try This at Home!
- Author
-
Thakar CV
- Subjects
- Humans, Renal Dialysis, Kidney Failure, Chronic therapy, Peritoneal Dialysis
- Published
- 2021
- Full Text
- View/download PDF
20. Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.
- Author
-
Reigle J, Secic D, Biesiada J, Wetzel C, Shamsaei B, Chu J, Zang Y, Zhang X, Talbot NJ, Bischoff ME, Zhang Y, Thakar CV, Gaitonde K, Sidana A, Bui H, Cunningham JT, Zhang Q, Schmidt LS, Linehan WM, Medvedovic M, Plas DR, Figueroa JAL, Meller J, and Czyzyk-Krzeska MF
- Subjects
- Carcinoma, Renal Cell pathology, Female, Humans, Kidney Neoplasms pathology, Male, Tobacco Smoking pathology, Carcinoma, Renal Cell metabolism, Cellular Reprogramming, Kidney Neoplasms metabolism, Tobacco Smoking adverse effects, Tobacco Smoking metabolism
- Abstract
BACKGROUNDClear cell renal cell carcinoma (ccRCC) is the most common histologically defined renal cancer. However, it is not a uniform disease and includes several genetic subtypes with different prognoses. ccRCC is also characterized by distinctive metabolic reprogramming. Tobacco smoking (TS) is an established risk factor for ccRCC, with unknown effects on tumor pathobiology.METHODSWe investigated the landscape of ccRCCs and paired normal kidney tissues using integrated transcriptomic, metabolomic, and metallomic approaches in a cohort of white males who were long-term current smokers (LTS) or were never smokers (NS).RESULTSAll 3 Omics domains consistently identified a distinct metabolic subtype of ccRCCs in LTS, characterized by activation of oxidative phosphorylation (OXPHOS) coupled with reprogramming of the malate-aspartate shuttle and metabolism of aspartate, glutamate, glutamine, and histidine. Cadmium, copper, and inorganic arsenic accumulated in LTS tumors, showing redistribution among intracellular pools, including relocation of copper into the cytochrome c oxidase complex. A gene expression signature based on the LTS metabolic subtype provided prognostic stratification of The Cancer Genome Atlas ccRCC tumors that was independent of genomic alterations.CONCLUSIONThe work identified the TS-related metabolic subtype of ccRCC with vulnerabilities that can be exploited for precision medicine approaches targeting metabolic pathways. The results provided rationale for the development of metabolic biomarkers with diagnostic and prognostic applications using evaluation of OXPHOS status. The metallomic analysis revealed the role of disrupted metal homeostasis in ccRCC, highlighting the importance of studying effects of metals from e-cigarettes and environmental exposures.FUNDINGDepartment of Defense, Veteran Administration, NIH, ACS, and University of Cincinnati Cancer Institute.
- Published
- 2021
- Full Text
- View/download PDF
21. Contraceptive Use Among Women With End-Stage Kidney Disease on Dialysis in the United States.
- Author
-
Shah S, Christianson AL, Thakar CV, Kramer S, Meganathan K, and Leonard AC
- Abstract
Rationale & Objective: Although end-stage kidney disease (ESKD) adversely affects fertility, pregnancies can occur among women receiving dialysis. ESKD increases the risk for adverse pregnancy outcomes and little is known about contraceptive use in women undergoing dialysis., Study Design: Retrospective cohort study., Setting & Participants: Using the US Renal Data System covering January 1, 2005, through December 31, 2014, we evaluated for each calendar year women who for the entire year were aged 15 to 44 years, receiving dialysis, and with Medicare as the primary payer., Predictors: Age, race/ethnicity, and calendar year of prevalent ESKD., Outcome: Contraceptive use., Analytic Approach: We determined rates of contraceptive use and used multivariable logistic regression to identify factors associated with contraceptive use., Results: The study cohort included 35,732 women and represented 115,713 person-years. The rate of contraceptive use was 5.30% of person-years (95% CI, 5.17%-5.42%). Overall, contraceptive use increased from 2005 to 2014 (4.21%; 95% CI, 3.84%-4.59% vs 6.54%, 95% CI, 6.10%-6.99%). Compared with women aged 25 to 29 years, contraceptive use was higher in women aged 15 to 24 years (OR, 1.30; 95% CI, 1.18-1.43) and lower in women aged 30 to 34 years (OR, 0.74; 95% CI, 0.68-0.81), 35 to 39 years (OR, 0.46; 95% CI, 0.42-0.50), and 40 to 44 years (OR, 0.30; 95% CI, 0.27-0.34). Compared with White women, contraceptive use was higher in Black (OR, 1.12; 95% CI, 1.02-1.24) and Native American women (OR, 1.60; 95% CI, 1.25-2.05). Women with ESKD due to glomerulonephritis had a higher likelihood of contraceptive use than women with ESKD due to diabetes (OR, 1.22; 95% CI, 1.06-1.42). Women receiving peritoneal dialysis had a lower likelihood of contraceptive use than women receiving hemodialysis (OR, 0.85; 95% CI, 0.78-0.93). Compared with women without predialysis nephrology care, contraceptive use was higher in women who received predialysis nephrology care for 12 or fewer months (OR, 1.22; 95% CI, 1.09-1.37) and more than 12 months (OR, 1.33; 95% CI, 1.20-1.47)., Limitations: Retrospective design and use of administrative data., Conclusions: Among women with ESKD undergoing dialysis, contraceptive use remains low at 5.30%. Younger age, Native American and Black race/ethnicity, ESKD due to glomerulonephritis, hemodialysis, and predialysis nephrology care are associated with a higher likelihood of contraceptive use. The study highlights the importance of prepregnancy counseling for contraceptive use in women receiving dialysis., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
22. Acetazolamide causes renal [Formula: see text] wasting but inhibits ammoniagenesis and prevents the correction of metabolic acidosis by the kidney.
- Author
-
Alam P, Amlal S, Thakar CV, and Amlal H
- Subjects
- Acetazolamide pharmacokinetics, Acid-Base Equilibrium drug effects, Adaptation, Physiological, Amino Acid Transport Systems, Neutral genetics, Amino Acid Transport Systems, Neutral metabolism, Animals, Chlorides blood, Diuretics pharmacokinetics, Electrolytes blood, Gene Expression Regulation drug effects, Half-Life, Kidney metabolism, Kidney pathology, Male, Rats, Rats, Sprague-Dawley, Urinalysis, Acetazolamide pharmacology, Acidosis metabolism, Ammonia metabolism, Bicarbonates metabolism, Diuretics pharmacology, Kidney drug effects
- Abstract
Carbonic anhydrase (CAII) binds to the electrogenic basolateral Na
+ -[Formula: see text] cotransporter (NBCe1) and facilitates [Formula: see text] reabsorption across the proximal tubule. However, whether the inhibition of CAII with acetazolamide (ACTZ) alters NBCe1 activity and interferes with the ammoniagenesis pathway remains elusive. To address this issue, we compared the renal adaptation of rats treated with ACTZ to NH4 Cl loading for up to 2 wk. The results indicated that ACTZ-treated rats exhibited a sustained metabolic acidosis for up to 2 wk, whereas in NH4 Cl-loaded rats, metabolic acidosis was corrected within 2 wk of treatment. [Formula: see text] excretion increased by 10-fold in NH4 Cl-loaded rats but only slightly (1.7-fold) in ACTZ-treated rats during the first week despite a similar degree of acidosis. Immunoblot experiments showed that the protein abundance of glutaminase (4-fold), glutamate dehydrogenase (6-fold), and SN1 (8-fold) increased significantly in NH4 Cl-loaded rats but remained unchanged in ACTZ-treated rats. Na+ /H+ exchanger 3 and NBCe1 proteins were upregulated in response to NH4 Cl loading but not ACTZ treatment and were rather sharply downregulated after 2 wk of ACTZ treatment. ACTZ causes renal [Formula: see text] wasting and induces metabolic acidosis but inhibits the upregulation of glutamine transporter and ammoniagenic enzymes and thus suppresses ammonia synthesis and secretion in the proximal tubule, which prevented the correction of acidosis. This effect is likely mediated through the inhibition of the CA-NBCe1 metabolon complex, which results in cell alkalinization. During chronic ACTZ treatment, the downregulation of both NBCe1 and Na+ /H+ exchanger 3, along with the inhibition of ammoniagenesis and [Formula: see text] generation, contributes to the maintenance of metabolic acidosis.- Published
- 2020
- Full Text
- View/download PDF
23. COVID-19 and Kidney Disease.
- Author
-
Thakar CV
- Subjects
- Humans, SARS-CoV-2, COVID-19, Kidney Diseases, Nephrology
- Published
- 2020
- Full Text
- View/download PDF
24. Future of Nephrology Workforce: Reimagining Educational Value.
- Author
-
Thakar CV
- Subjects
- Faculty, Medical, Forecasting, Humans, Knowledge, Teaching, Thinking, Health Workforce trends, Nephrology education, Nephrology trends
- Published
- 2020
- Full Text
- View/download PDF
25. Mortality and Recovery Associated with Kidney Failure due to Acute Kidney Injury.
- Author
-
Shah S, Leonard AC, Harrison K, Meganathan K, Christianson AL, and Thakar CV
- Subjects
- Acute Kidney Injury physiopathology, Acute Kidney Injury therapy, Adolescent, Adult, Black or African American statistics & numerical data, Aged, Aged, 80 and over, Asian statistics & numerical data, Databases, Factual, Female, Hispanic or Latino statistics & numerical data, Humans, Male, Middle Aged, Renal Dialysis statistics & numerical data, Renal Insufficiency ethnology, Renal Insufficiency physiopathology, Retrospective Studies, Sex Factors, United States epidemiology, White People statistics & numerical data, Young Adult, American Indian or Alaska Native statistics & numerical data, Acute Kidney Injury complications, Recovery of Function, Renal Insufficiency etiology, Renal Insufficiency mortality
- Abstract
Background and Objectives: AKI requiring dialysis is a contributor to the growing burden of kidney failure, yet little is known about the frequency and patterns of recovery of AKI and its effect on outcomes in patients on incident dialysis., Design, Setting, Participants, & Measurements: Using the US Renal Data System, we evaluated a cohort of 1,045,540 patients on incident dialysis from January 1, 2005 to December 31, 2014, retrospectively. We examined the association of kidney failure due to AKI with the outcome of all-cause mortality and the associations of sex and race with kidney recovery., Results: Mean age was 63±15 years, and 32,598 (3%) patients on incident dialysis had kidney failure due to AKI. Compared with kidney failure due to diabetes mellitus, kidney failure attributed to AKI was associated with a higher mortality in the first 0-3 months following dialysis initiation (adjusted hazard ratio, 1.28; 95% confidence interval, 1.24 to 1.32) and 3-6 months (adjusted hazard ratio, 1.16; 95% confidence interval, 1.11 to 1.20). Of the patients with kidney failure due to AKI, 11,498 (35%) eventually recovered their kidney function, 95% of those within 12 months. Women had a lower likelihood of kidney recovery than men (adjusted hazard ratio, 0.86; 95% confidence interval, 0.83 to 0.90). Compared with whites, blacks (adjusted hazard ratio, 0.68; 95% confidence interval, 0.64 to 0.72), Asians (adjusted hazard ratio, 0.82; 95% confidence interval, 0.69 to 0.96), Hispanics (adjusted hazard ratio, 0.82; 95% confidence interval, 0.76 to 0.89), and Native Americans (adjusted hazard ratio, 0.72; 95% confidence interval, 0.54 to 0.95) had lower likelihoods of kidney recovery., Conclusions: Kidney failure due to AKI confers a higher risk of mortality in the first 6 months compared with kidney failure due to diabetes or other causes. Recovery within 12 months is common, although less so among women than men and among black, Asian, Hispanic, and Native American patients than white patients., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
26. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.
- Author
-
Eckman MH, Woodle ES, Thakar CV, Alloway RR, and Sherman KE
- Subjects
- Adult, Antiviral Agents economics, Antiviral Agents therapeutic use, Cost-Benefit Analysis, Donor Selection economics, Donor Selection methods, Drug Combinations, Female, Humans, Male, Middle Aged, Outcome and Process Assessment, Health Care, Sofosbuvir, Uridine Monophosphate therapeutic use, Viremia diagnosis, Viremia etiology, Benzimidazoles therapeutic use, Fluorenes therapeutic use, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic drug therapy, Hepatitis C, Chronic etiology, Hepatitis C, Chronic virology, Kidney Failure, Chronic surgery, Kidney Transplantation adverse effects, Kidney Transplantation methods, Postoperative Complications drug therapy, Postoperative Complications economics, Postoperative Complications virology, Pyrrolidines therapeutic use, Quinoxalines therapeutic use, Sulfonamides therapeutic use, Uridine Monophosphate analogs & derivatives
- Abstract
Rationale & Objective: Less than 4% of patients with kidney failure receive kidney transplants. Although discard rates of hepatitis C virus (HCV)-viremic kidneys are declining, ~39% of HCV-viremic kidneys donated between 2018 and 2019 were discarded. Highly effective antiviral agents are now available to treat chronic HCV infection. Thus, our objective was to examine the cost-effectiveness of transplanting kidneys from HCV-viremic donors into HCV-uninfected recipients., Study Design: Markov state transition decision model. Data sources include Medline search results, bibliographies from relevant English language articles, Scientific Registry of Transplant Recipients, and the US Renal Data System., Setting & Population: US patients receiving maintenance hemodialysis who are on kidney transplant waiting lists., Intervention(s): Transplantation with an HCV-unexposed kidney versus transplantation with an HCV-viremic kidney and HCV treatment., Outcomes: Effectiveness measured in quality-adjusted life-years and costs measured in 2018 US dollars., Model, Perspective, and Timeframe: We used a health care system perspective with a lifelong time horizon., Results: In the base-case analysis, transplantation with an HCV-viremic kidney was more effective and less costly than transplantation with an HCV-unexposed kidney because of the longer waiting times for HCV-unexposed kidneys, the substantial excess mortality risk while receiving dialysis, and the high efficacy of direct-acting antiviral agents for HCV infection. Transplantation with an HCV-viremic kidney was also preferred in sensitivity analyses of multiple model parameters. The strategy remained cost-effective unless waiting list time for an HCV-viremic kidney exceeded 3.1 years compared with the base-case value of 1.56 year., Limitations: Estimates of waiting times for patients willing to accept an HCV-viremic kidney were based on data for patients who received HCV-viremic kidney transplants., Conclusions: Transplanting kidneys from HCV-viremic donors into HCV-uninfected recipients increased quality-adjusted life expectancy and reduced costs compared with a strategy of transplanting kidneys from HCV-unexposed donors., (Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
27. Interventional Nephrology: What, Who, Why?
- Author
-
Thakar CV
- Subjects
- Humans, Vascular Access Devices, Arteriovenous Shunt, Surgical methods, Arteriovenous Shunt, Surgical trends, Nephrology methods, Nephrology trends, Renal Dialysis methods, Renal Insufficiency therapy
- Published
- 2020
- Full Text
- View/download PDF
28. Pregnancy-Related Acute Kidney Injury in the United States: Clinical Outcomes and Health Care Utilization.
- Author
-
Shah S, Meganathan K, Christianson AL, Harrison K, Leonard AC, and Thakar CV
- Subjects
- Acute Kidney Injury complications, Acute Kidney Injury therapy, Adolescent, Adult, Black or African American statistics & numerical data, Female, Heart Disease Risk Factors, Hospital Mortality, Hospitalization statistics & numerical data, Humans, Male, Middle Aged, Pregnancy, Pregnancy Complications, Cardiovascular etiology, Pregnancy Complications, Cardiovascular therapy, Retrospective Studies, United States epidemiology, White People statistics & numerical data, Young Adult, American Indian or Alaska Native statistics & numerical data, Acute Kidney Injury epidemiology, Patient Acceptance of Health Care statistics & numerical data, Pregnancy Complications, Cardiovascular epidemiology, Renal Dialysis statistics & numerical data
- Abstract
Background: Acute kidney injury (AKI) during pregnancy is a public health problem and is associated with maternal and fetal morbidity and mortality. Clinical outcomes and health care utilization in pregnancy-related AKI, especially in women with diabetes, are not well studied., Methods: Using data from the 2006 to 2015 Nationwide Inpatient Sample, we identified 42,190,790 pregnancy-related hospitalizations in women aged 15-49 years. We determined factors associated with AKI, including race/ethnicity, and associations between AKI and inpatient mortality, and between AKI and cardiovascular (CV) events, during pregnancy-related hospitalizations. We calculated health care expenditures from pregnancy-related AKI hospitalizations., Results: Overall, the rate of AKI during pregnancy-related hospitalizations was 0.08%. In the adjusted regression analysis, a higher likelihood of AKI during pregnancy-related hospitalizations was seen in 2015 (OR 2.20; 95% CI 1.89-2.55) than in 2006; in older women aged 36-40 years (OR 1.49; 95% CI 1.36-1.64) and 41-49 years (OR 2.12; 95% CI 1.84-2.45) than in women aged 20-25 years; in blacks (OR 1.52; 95% CI 1.40-1.65) and Native Americans (OR 1.45; 95% CI 1.10-1.91) than in whites, and in diabetic women (OR 4.43; 95% CI 4.04-4.86) than in those without diabetes. Pregnancy-related hospitalizations with AKI were associated with a higher likelihood of inpatient mortality (OR 13.50; 95% CI 10.47-17.42) and CV events (OR 9.74; 95% CI 9.08-10.46) than were hospitalizations with no AKI. The median cost was higher for a delivery hospitalization with AKI than without AKI (USD 18,072 vs. 4,447)., Conclusion: The rates of pregnancy-related AKI hospitalizations have increased during the last decade. Factors associated with a higher likelihood of AKI during pregnancy included older age, black and Native American race/ethnicity, and diabetes. Hospitalizations with pregnancy-related AKI have an increased risk of inpatient mortality and CV events, and a higher health care utilization than do those without AKI., (The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
29. Toxicology and Kidney: Not so Innocent Bystander.
- Author
-
Thakar CV
- Subjects
- Acute Kidney Injury diagnosis, Acute Kidney Injury therapy, Humans, Acute Kidney Injury chemically induced
- Published
- 2020
- Full Text
- View/download PDF
30. Racial Differences and Factors Associated with Pregnancy in ESKD Patients on Dialysis in the United States.
- Author
-
Shah S, Christianson AL, Meganathan K, Leonard AC, Schauer DP, and Thakar CV
- Subjects
- Adolescent, Adult, Black or African American statistics & numerical data, Comorbidity, Female, Glomerulonephritis complications, Glomerulonephritis ethnology, Hispanic or Latino statistics & numerical data, Humans, Hypertension complications, Hypertension ethnology, Indians, North American statistics & numerical data, Kidney Failure, Chronic etiology, Kidney Failure, Chronic therapy, Medicare, Neoplasms complications, Neoplasms ethnology, Peritoneal Dialysis statistics & numerical data, Pregnancy, Pregnancy Complications therapy, Pregnancy Outcome, Pregnancy Rate, Retrospective Studies, United States epidemiology, White People statistics & numerical data, Young Adult, Kidney Failure, Chronic ethnology, Pregnancy Complications ethnology, Renal Dialysis statistics & numerical data
- Abstract
Background: Pregnancy in women with ESKD undergoing dialysis is uncommon due to impaired fertility. Data on pregnancy in women on dialysis in the United States is scarce., Methods: We evaluated a retrospective cohort of 47,555 women aged 15-44 years on dialysis between January 1, 2005 and December 31, 2013 using data from the United States Renal Data System with Medicare as primary payer. We calculated pregnancy rates and identified factors associated with pregnancy., Results: In 47,555 women on dialysis, 2352 pregnancies were identified. Pregnancy rate was 17.8 per thousand person years (PTPY) with the highest rate in women aged 20-24 (40.9 PTPY). In the adjusted time-to-event analysis, a higher likelihood of pregnancy was seen in Native American (HR, 1.77; 95% CI, 1.33 to 2.36), Hispanic (HR, 1.51; 95% CI, 1.32 to 1.73), and black (HR, 1.33; 95% CI, 1.18 to 1.49) women than in white women. A higher rate of pregnancy was seen in women with ESKD due to malignancy (HR, 1.64; 95% CI, 1.27 to 2.12), GN (HR, 1.38; 95% CI, 1.21 to 1.58), hypertension (HR, 1.32; 95% CI, 1.16 to 1.51), and secondary GN/vasculitis (HR, 1.18; 95% CI, 1.02 to 1.37) than ESKD due to diabetes. A lower likelihood of pregnancy was seen among women on peritoneal dialysis than on hemodialysis (HR, 0.47; 95% CI, 0.41 to 0.55)., Conclusions: The pregnancy rate is higher in women on dialysis than previous reports indicate. A higher likelihood of pregnancy was associated with race/ethnicity, ESKD cause, and dialysis modality., (Copyright © 2019 by the American Society of Nephrology.)
- Published
- 2019
- Full Text
- View/download PDF
31. Racial disparities and factors associated with pregnancy in kidney transplant recipients in the United States.
- Author
-
Shah S, Christianson AL, Verma P, Meganathan K, Leonard AC, Schauer DP, and Thakar CV
- Subjects
- Adult, Cohort Studies, Female, Humans, Logistic Models, Multivariate Analysis, Odds Ratio, Pregnancy, United States epidemiology, Kidney Transplantation, Racism, Transplant Recipients
- Abstract
Background: Although kidney transplant improves reproductive function in women with end-stage kidney disease (ESKD), pregnancy in kidney transplant recipients' remains challenging due to the risk of adverse maternal and fetal outcomes., Methods: We evaluated a retrospective cohort of 7,966 women who were aged 15-45 years and received a kidney transplant between January 1, 2005 and December 31, 2011 from the United States Renal Data System with Medicare as the primary payer for the entire three years after the date of transplantation. Unadjusted and adjusted rates of pregnancy in the first three post-transplant years were calculated, using Poisson regression for the adjustment. Factors associated with pregnancy, including race, were examined using logistic regression., Results: Overall, 293 pregnancies were identified in 7966 women. The unadjusted pregnancy rate was 13.8 per thousand person-years (PTPY) (95% confidence interval (CI), 12.3-15.5). Pregnancy rates were roughly constant in the years 2005-2011 except in 2005 and 2010. The rate of pregnancy was highest in Hispanic women (21.4 PTPY; 95% CI, 17.2-26.4) and Hispanic women had a higher likelihood of pregnancy as compared to white women (OR, 1.56; CI, 1.12-2.16). Pregnancy rates were lowest in women aged 30-34 years and 35-45 years at transplant, and women aged 30-34 years and 35-45 years at transplant were less likely to ever become pregnant during the follow-up (odds ratio [OR], 0.69; CI, 0.49-0.98 and OR, 0.14; CI 0.09-0.21 respectively) as compared to women aged 25-29 years at time of transplant. Women had higher rates of pregnancy in the second and third-year post-transplant (16.0 PTPY, CI 13.2-19.2 and 16.9 PTPY, CI 14.0-20.4) than in the first-year post-transplant (9.0 PTPY, CI 7.0-11.4). In transplant recipients, pregnancy was more likely in women with ESKD due to cystic disease (OR, 2.42; CI, 1.02-5.74) or glomerulonephritis (OR, 2.14; CI, 1.07-4.31) as compared to women with ESKD due to diabetes., Conclusion: Hispanic race, younger age, and ESKD cause due to cystic disease or glomerulonephritis are significant factors associated with a higher likelihood of pregnancy. Pregnancy rates have been fairly constant over the last decade. This study improves our understanding of factors associated with pregnancy in kidney transplant recipients., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
32. Acute Kidney Injury, Heart Failure, and Health Outcomes.
- Author
-
Gudsoorkar PS and Thakar CV
- Subjects
- Global Health, Humans, Morbidity trends, Prognosis, Survival Rate trends, Acute Kidney Injury epidemiology, Acute Kidney Injury etiology, Acute Kidney Injury therapy, Glomerular Filtration Rate physiology, Health Status, Heart Failure complications, Heart Failure epidemiology, Heart Failure therapy, Hemodynamics physiology, Ultrafiltration methods
- Abstract
Acute kidney injury in acute decompensated heart failure leads to increased readmissions regardless of being transient or sustained at the time of discharge. Timely identification of acute kidney injury and worsening heart failure in patients with acute decompensated heart failure is of utmost importance to optimize different components of heart failure treatment. Acute kidney injury is a strong predictor of poor outcomes and early death in patients with pulmonary artery hypertension and acute right-sided heart failure. Extracorporeal ultrafiltration should not be used as an initial or alternative to diuretic therapy. It should be reserved for diuretic-resistant individuals., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
33. Diabetes/Kidney/Heart Disease.
- Author
-
Shah S and Thakar CV
- Subjects
- Comorbidity, Diabetes Mellitus therapy, Heart Diseases therapy, Humans, Renal Insufficiency, Chronic therapy, United States epidemiology, Delivery of Health Care methods, Diabetes Mellitus epidemiology, Disease Management, Heart Diseases epidemiology, Renal Insufficiency, Chronic epidemiology
- Published
- 2019
- Full Text
- View/download PDF
34. Perceptions of nephrology among medical students and internal medicine residents: a national survey among institutions with nephrology exposure.
- Author
-
Nair D, Pivert KA, Baudy A 4th, and Thakar CV
- Subjects
- Adult, Attitude, Female, Humans, Male, Needs Assessment, Quality Improvement, Social Perception, United States, Career Choice, Internship and Residency, Nephrology education, Students, Medical psychology
- Abstract
Background: Fewer trainees are choosing to pursue nephrology. Only 60.1% of positions filled in the 2018 fellowship Match, which is concerning given the rising prevalence of end-stage kidney disease. Identifying factors influential in career choices is critical to inform focused approaches to recruit qualified applicants., Methods: To understand perceptions of nephrology and assess factors influential in specialty choice among early career trainees, an anonymous survey was distributed to upper-level medical students and internal medicine residents at programs identified through the American Association of Medical Colleges (AAMC) and American Medical Association's Fellowship and Residency Electronic Interactive Database (FREIDA)., Results: Of 4199 recipients, 644 (15.3%) participants responded, including 315 upper-level medical students, 308 residents, and three chief residents from 30 institutions. An interest in the subject was the most critical factor in selecting a specialty (92%). Other key factors included a suitable work-life balance (73%), access to mentors (70%), and subject exposure (66%). Lack of interest was the most frequently-cited reason to forgo a nephrology fellowship (79%), followed by concerns regarding remuneration (43%), work-life balance (39%), and subject exposure (32%). In free-text responses, several participants described frustration with managing patients on hemodialysis and desired combined training with specialties such as critical care. Respondents who had considered nephrology at any point cited an interest in physiology or interface with a mentor as key driving factors., Conclusions: A lack of interest in and exposure to the subject, perceptions of poor earning potential and patient nonadherence, and concerns regarding work-life balance were influential in participants' decisions to forgo nephrology training. Incorporating novel educational tools and broadening the scope of the nephrology elective, highlighting ongoing areas of clinical and research innovation, expanding opportunities for interdisciplinary collaboration and procedural skills, and cultivating strategies to reduce burnout may be useful areas on which to focus future recruitment efforts.
- Published
- 2019
- Full Text
- View/download PDF
35. Adenine acts in the kidney as a signaling factor and causes salt- and water-losing nephropathy: early mechanism of adenine-induced renal injury.
- Author
-
Dos Santos IF, Sheriff S, Amlal S, Ahmed RPH, Thakar CV, and Amlal H
- Subjects
- Animals, Aquaporin 2 antagonists & inhibitors, Arginine Vasopressin pharmacology, Cyclic AMP metabolism, Diet, Dose-Response Relationship, Drug, Eating, Kidney pathology, Kidney Diseases pathology, Male, Osmolar Concentration, Rats, Rats, Sprague-Dawley, Sodium Chloride pharmacology, Solute Carrier Family 12, Member 1 antagonists & inhibitors, Water metabolism, Water-Electrolyte Balance drug effects, Adenine toxicity, Kidney drug effects, Kidney Diseases chemically induced, Kidney Diseases metabolism, Signal Transduction drug effects
- Abstract
Chronic adenine feeding is extensively used to develop animal models of chronic renal failure with metabolic features resembling those observed in humans. However, the mechanism by which adenine induces renal failure is poorly understood. In this study, we examined the early effects of adenine on water metabolism and salt balance in rats placed in metabolic cages and fed control or adenine-containing diets for 7 days. Molecular and functional studies demonstrated that adenine-fed rats exhibited a significant reduction in food intake, polyuria, polydipsia, decreased urine osmolality, and increased salt wasting. These effects are independent of changes in food intake and result from a coordinated downregulation of water channel aquaporin-2 (AQP2) and salt transporter (Na
+ -K+ -Cl- cotransporter 2; NKCC2) in the collecting duct and medullary thick ascending limb, respectively. As a result, adenine-fed rats exhibited massive volume depletion, as indicated by a significant body weight loss, increased blood urea nitrogen, and increased hematocrit and hemoglobin levels, all of which were significantly corrected with NaCl replacement. Adenine-induced urinary concentrating defect was not corrected by exogenous arginine vasopressin (AVP), and it correlated with reduced cAMP production in vivo and in vitro. In conclusion, adenine acts on renal tubules as a signaling molecule and causes nephrogenic diabetes insipidus with salt wasting, at least, by directly interfering with AVP V2 receptor signaling with subsequent downregulation of NKCC2 and AQP2 in the kidney. The combination of renal fluid loss and decreased food intake with subsequent massive volume depletion likely plays an important role in the development of early prerenal failure that progresses to chronic kidney disease in long-term adenine feeding.- Published
- 2019
- Full Text
- View/download PDF
36. Pre-dialysis acute care hospitalizations and clinical outcomes in dialysis patients.
- Author
-
Shah S, Meganathan K, Christianson AL, Leonard AC, and Thakar CV
- Subjects
- Adult, Aged, Aged, 80 and over, Dialysis adverse effects, Female, Hospitalization, Humans, Kidney Failure, Chronic mortality, Logistic Models, Male, Middle Aged, Odds Ratio, Prognosis, Regression Analysis, Renal Dialysis mortality, Renal Insufficiency, Chronic mortality, Retrospective Studies, United States, Dialysis methods, Kidney Failure, Chronic therapy, Renal Dialysis methods, Renal Insufficiency, Chronic therapy
- Abstract
Background: Patients with chronic kidney disease (CKD), a precursor of end stage renal disease (ESRD), face an increasing burden of hospitalizations. Although mortality on dialysis is highest during the first year, the impact of pre-dialysis acute hospitalizations on clinical outcomes in dialysis patients remains unknown., Methods: We evaluated 170,897 adult patients who initiated dialysis between 1/1/2010 and 12/31/2014 with linked Medicare claims from the United States Renal Data System. Using logistic regression models, we examined the association of 2-year pre-dialysis hospitalization on the primary outcome of 1-year all-cause mortality. Secondary outcomes included 90-day mortality, type of initial dialysis modality and type of vascular access at hemodialysis initiation., Results: Mean age was 72.7 ± 11.0 years. In the study sample, 76.0% of patients had at least one pre-dialysis hospitalization. Compared to patients with no pre-dialysis hospitalization, the adjusted 1-year mortality was higher with pre-dialysis cardiovascular related hospitalization (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.57-1.68), infection related hospitalization (OR, 1.51; CI, 1.45-1.57), both cardiovascular and infection hospitalization (OR, 1.91; CI, 1.83-1.99), and neither-cardiovascular nor-infection hospitalization (OR, 1.23; CI, 1.19-1.27). Additionally, the adjusted odds of hemodialysis vs. peritoneal dialysis as the initial dialysis modality were higher, whereas adjusted odds to initiate hemodialysis with an arteriovenous access vs. central venous catheter were lower in patients with any type of hospitalization., Conclusion: Pre-dialysis hospitalization is an independent predictor of 1-year mortality in dialysis patients. Reducing the risk of pre-dialysis hospitalization may provide opportunities to improve quality of care in ESRD., Competing Interests: All the authors have no disclosures and competing interests. The results presented in this paper have not been published previously in whole or part, except in abstract format. The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. The study was reviewed and deemed exempt by the University of Cincinnati institutional review board since the data was de identified. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2019
- Full Text
- View/download PDF
37. Temporal Trends in Incident Mortality in Dialysis Patients: Focus on Sex and Racial Disparities.
- Author
-
Shah S, Leonard AC, Meganathan K, Christianson AL, and Thakar CV
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Kidney Failure, Chronic therapy, Male, Middle Aged, Racial Groups statistics & numerical data, Retrospective Studies, Risk Factors, Sex Factors, Treatment Outcome, United States epidemiology, Young Adult, Health Status Disparities, Kidney Failure, Chronic mortality, Mortality trends, Renal Dialysis
- Abstract
Background: Racial minorities and women constitute substantial portions of the incident and prevalent end-stage renal disease (ESRD) population in the United States. Although ESRD is characterized by high mortality, temporal trends, and race and sex differences in mortality have not been studied., Methods: We evaluated 944,650 adult patients who initiated dialysis between January 1, 2005 and December 31, 2014, using the United States Renal Data System, for sex-related and race-related trends in mortality. Logistic regression models adjusted for pre-dialysis health status were used to examine associations among the predictors' sex, race, and year of incident dialysis, and the outcome all-cause mortality at 1-year post ESRD., Results: The mean age was 65 ± 14 years. The 1-year crude mortality rates in incident ESRD patients decreased by 28% from 2004 to 2015. Risk-adjusted 1-year mortality decreased by 3% for each later year of incident ESRD (p < 0.001). In general, from 2005 to 2014, mortality rates decreased across both sexes, and all races. White patients experienced the lowest reduction in adjusted 1-year mortality rates (16%). While women experienced a survival advantage over men in 2005, by 2014 it was reversed to survival advantage for men. Combining all years, the adjusted risk of dying at 1-year after initiating dialysis was lower in women than men (OR 0.98; 95% CI 0.97-0.99), and as compared to whites, was lower in blacks (OR 0.73; 95% CI -0.72-0.74), Hispanics (OR 0.64; 95% CI 0.63-0.65), Asians (OR 0.55; 95% CI 0.53-0.56), and Native Americans (OR 0.67; 95% CI 0.63-0.71)., Conclusion: The 1-year mortality rates among patients with ESRD have decreased steadily during a recent 10-year period across both men and women, and in all 5 races. Women have only a 2% lower risk of dying at 1-year after dialysis initiation than men. White patients had higher mortality as compared to other races. Our results suggest the need for sex, and race-specific treatment strategies in ESRD care., (© 2019 S. Karger AG, Basel.)
- Published
- 2019
- Full Text
- View/download PDF
38. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.
- Author
-
Eckman MH, Woodle ES, Thakar CV, Paterno F, and Sherman KE
- Subjects
- Cost-Benefit Analysis, Humans, Kidney, Hepacivirus, Hepatitis C
- Published
- 2018
- Full Text
- View/download PDF
39. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.
- Author
-
Eckman MH, Woodle ES, Thakar CV, Paterno F, and Sherman KE
- Subjects
- Comparative Effectiveness Research, Hepatitis C, Chronic complications, Humans, Kidney Failure, Chronic complications, Kidney Failure, Chronic therapy, Markov Chains, Middle Aged, Quality-Adjusted Life Years, Renal Dialysis, Sensitivity and Specificity, Antiviral Agents therapeutic use, Cost-Benefit Analysis, Hepatitis C, Chronic drug therapy, Kidney Failure, Chronic surgery, Kidney Failure, Chronic virology, Kidney Transplantation economics, Tissue Donors
- Abstract
Background: Direct-acting antiviral agents are now available to treat chronic hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD)., Objective: To examine whether it is more cost-effective to transplant HCV-infected or HCV-uninfected kidneys into HCV-infected patients., Design: Markov state-transition decision model., Data Sources: MEDLINE searches and bibliographies from relevant English-language articles., Target Population: HCV-infected patients with ESRD receiving hemodialysis in the United States., Time Horizon: Lifetime., Perspective: Health care system., Intervention: Transplant of an HCV-infected kidney followed by HCV treatment versus transplant of an HCV-uninfected kidney preceded by HCV treatment., Outcome Measures: Effectiveness, measured in quality-adjusted life-years (QALYs), and costs, measured in 2017 U.S. dollars., Results of Base-Case Analysis: Transplant of an HCV-infected kidney followed by HCV treatment was more effective and less costly than transplant of an HCV-uninfected kidney preceded by HCV treatment, largely because of longer wait times for uninfected kidneys. A typical 57.8-year-old patient receiving hemodialysis would gain an average of 0.50 QALY at a lifetime cost savings of $41 591., Results of Sensitivity Analysis: Transplant of an HCV-infected kidney followed by HCV treatment continued to be preferred in sensitivity analyses of many model parameters. Transplant of an HCV-uninfected kidney preceded by HCV treatment was not preferred unless the additional wait time for an uninfected kidney was less than 161 days., Limitation: The study did not consider the benefit of decreased HCV transmission from treating HCV-infected patients., Conclusion: Transplanting HCV-infected kidneys into HCV-infected patients increased quality-adjusted life expectancy and reduced costs compared with transplanting HCV-uninfected kidneys into HCV-infected patients., Primary Funding Source: Merck Sharp & Dohme and the National Center for Advancing Translational Sciences.
- Published
- 2018
- Full Text
- View/download PDF
40. Functional status, pre-dialysis health and clinical outcomes among elderly dialysis patients.
- Author
-
Shah S, Leonard AC, and Thakar CV
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Arteriovenous Shunt, Surgical, Catheterization, Central Venous, Cause of Death, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Peritoneal Dialysis, Retrospective Studies, Treatment Outcome, United States, Young Adult, Health Status, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Renal Dialysis methods
- Abstract
Background: Elderly patients comprise the fastest growing population initiating dialysis in United States. The impact of poor functional status and pre-dialysis health status on clinical outcomes in elderly dialysis patients is not well studied., Methods: We studied a retrospective cohort of 49,645 incident end stage renal disease patients that initiated dialysis between January 1, 2008 and December 31, 2008 from the United States Renal Data System with linked Medicare data covering at least 2 years prior to dialysis initiation. Using logistic regression models adjusted for pre-dialysis health status and other cofounders, we examined the impact of poor functional status as defined from form 2728 on 1-year all-cause mortality as primary outcome, type of dialysis modality (hemodialysis vs. peritoneal dialysis), and type of initial vascular access (arteriovenous access vs. central venous catheter) among hemodialysis patients as secondary outcomes., Results: Mean age was 72 ± 11 years. At dialysis initiation, 18.7% reported poor functional status, 88.9% had at least 1 pre-dialysis hospitalization, and 27.8% did not receive pre-dialysis nephrology care. In adjusted analyses, 1-year mortality was higher in patients with poor functional status (OR, 1.48; 95% CI, 1.40-1.57). Adjusted odds of being initiated on hemodialysis than peritoneal dialysis (odds ratio [OR], 1.39; 95% confidence interval [CI], 1.16-1.66) were higher in patients with poor functional status. Poor functional status decreased the adjusted odds of starting hemodialysis with arteriovenous access as compared to central venous catheter (OR, 0.79; 95% CI, 0.72-0.86)., Conclusion: Poor functional status in elderly patients with end stage renal disease is associated with higher odds of initiating hemodialysis; increases the risk of central venous catheter use, and is an independent predictor of 1-year mortality.
- Published
- 2018
- Full Text
- View/download PDF
41. Acute Kidney Injury before Dialysis Initiation Predicts Adverse Outcomes in Hemodialysis Patients.
- Author
-
Lee T, Shah S, Leonard AC, Parikh P, and Thakar CV
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Prognosis, Retrospective Studies, Acute Kidney Injury complications, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
Background: Acute kidney injury (AKI) is associated with increased morbidity and mortality. Mortality in end-stage renal disease (ESRD) patients is highest during the first year of dialysis. The impact of pre-ESRD AKI events on long-term outcomes in incident ESRD patients remains unknown., Methods: We evaluated a retrospective cohort of 47,341 incident hemodialysis patients from the United States Renal Data System with linked Medicare data for at least 2 years prior to hemodialysis initiation. We examined the impact of pre-ESRD AKI events in the 2-year pre-ESRD period on the type of vascular access used at hemodialysis initiation (central venous catheter (CVC) versus arteriovenous access), and 1-year all-cause mortality after initiating hemodialysis., Results: The mean age was 72 ± 11 years. Of the study cohort, 18% initiated hemodialysis with arteriovenous access, and 54% of patients had at least one pre-ESRD AKI event. One-year, all-cause mortality was 32%. Compared to 75% for patients without a pre-ESRD AKI event, 89% of patients with a pre-ESRD AKI event initiated hemodialysis with CVC than arteriovenous access (p < 0.001). A pre-ESRD AKI event was associated with lower adjusted odds of starting hemodialysis with an arteriovenous access (OR 0.47; 95% CI 0.44-0.50, p < 0.001), and higher adjusted odds of 1-year mortality (OR 1.36; 95% CI 1.30-1.42, p < 0.001)., Conclusion: An AKI event prior to initiating hemodialysis independently increases the risk of CVC use and predicts 1-year mortality. Improving processes of care after AKI events may improve dialysis outcomes in patients who progress to ESRD., (© 2018 S. Karger AG, Basel.)
- Published
- 2018
- Full Text
- View/download PDF
42. Gender and Racial Disparities in Initial Hemodialysis Access and Outcomes in Incident End-Stage Renal Disease Patients.
- Author
-
Shah S, Leonard AC, Meganathan K, Christianson AL, and Thakar CV
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Kidney Failure, Chronic mortality, Male, Middle Aged, Racial Groups statistics & numerical data, Renal Dialysis methods, Retrospective Studies, Sex Factors, United States epidemiology, Young Adult, Arteriovenous Shunt, Surgical statistics & numerical data, Central Venous Catheters statistics & numerical data, Healthcare Disparities statistics & numerical data, Kidney Failure, Chronic therapy, Renal Dialysis statistics & numerical data
- Abstract
Background: Arteriovenous (AV) access confers survival benefits over central venous catheters (CVC) in hemodialysis patients. Although chronic kidney disease disproportionately affects women and racial minorities, disparities in the -utilization of hemodialysis access across Asians, Native Americans, Hispanics, blacks, and whites among males and females after accounting for pre-dialysis health are not well studied., Methods: We evaluated 885,699 patients with end-stage renal disease who initiated hemodialysis between January 1, 2004 and December 31, 2014 using the US Renal Data System. Multivariable logistic regression models -adjusted for pre-dialysis health were used to test the associations between gender and race on type of vascular access (AV access vs. CVC, and AV fistula vs. AV graft) at hemodialysis initiation as primary outcome, and on 1-year mortality as a secondary outcome., Results: Mean age was 65 ± 14 years. Females were less likely to use AV access for hemodialysis initiation than were males (OR 0.85; 95% CI 0.84-0.86). Compared to whites, adjusted odds of AV access for hemodialysis initiation were higher in blacks (OR 1.08; 95% CI 1.07-1.70), Asians (OR 1.11; 95% CI 1.07-1.14); and lower in Hispanics (OR 0.89; 95% CI 0.87-0.90). There was no -significant difference in mortality between males and females. Compared to whites, 1-year adjusted mortality was lower in Asians (OR 0.55; 95% CI 0.53-0.56), blacks (OR 0.67; 95% CI 0.66-0.68), Hispanics (OR 0.62; 95% CI 0.61-0.63), and Native Americans (OR 0.62; 95% CI 0.58-0.66)., Conclusion: Females had lower odds of using AV access than do males for hemodialysis initiation. As compared to whites, blacks and Asians were more likely, and Hispanics were less likely to use AV access for first outpatient hemodialysis. Further investigation of biological and process of care factors may help in developing ways to reduce these disparities., (The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2018
- Full Text
- View/download PDF
43. Temporal trends of dialysis requiring acute kidney injury after orthotopic cardiac and liver transplant hospitalizations.
- Author
-
Nadkarni GN, Chauhan K, Patel A, Saha A, Poojary P, Kamat S, Patel S, Ferrandino R, Konstantinidis I, Garimella PS, Menon MC, and Thakar CV
- Subjects
- Acute Kidney Injury diagnosis, Adolescent, Adult, Aged, Cohort Studies, Female, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, Young Adult, Acute Kidney Injury epidemiology, Heart Transplantation trends, Hospitalization trends, Liver Transplantation trends, Renal Dialysis trends
- Abstract
Background: The epidemiology and outcomes of acute kidney injury (AKI) in prevalent non-renal solid organ transplant recipients is unknown., Methods: We assessed the epidemiology of trends in acute kidney injury (AKI) in orthotopic cardiac and liver transplant recipients in the United States. We used the Nationwide Inpatient Sample to evaluate the yearly incidence trends (2002 to 2013) of the primary outcome, defined as AKI requiring dialysis (AKI-D) in hospitalizations after cardiac and liver transplantation. We also evaluated the trend and impact of AKI-D on hospital mortality and adverse discharge using adjusted odds ratios (aOR)., Results: The proportion of hospitalizations with AKI (9.7 to 32.7% in cardiac and 8.5 to 28.1% in liver transplant hospitalizations; p
trend <0.01) and AKI-D (1.63 to 2.33% in cardiac and 1.32 to 2.65% in liver transplant hospitalizations; ptrend <0.01) increased from 2002-2013. This increase in AKI-D was explained by changes in race and increase in age and comorbidity burden of transplant hospitalizations. AKI-D was associated with increased odds of in hospital mortality (aOR 2.85; 95% CI 2.11-3.80 in cardiac and aOR 2.00; 95% CI 1.55-2.59 in liver transplant hospitalizations) and adverse discharge [discharge other than home] (aOR 1.97; 95% CI 1.53-2.55 in cardiac and 1.91; 95% CI 1.57-2.30 in liver transplant hospitalizations)., Conclusions: This study highlights the growing burden of AKI-D in non-renal solid organ transplant recipients and its devastating impact, and emphasizes the need to develop strategies to reduce the risk of AKI to improve health outcomes.- Published
- 2017
- Full Text
- View/download PDF
44. Acute Kidney Injury: A Paradigm in Quality and Patient Safety.
- Author
-
Thakar CV
- Subjects
- Acute Kidney Injury etiology, Humans, Acute Kidney Injury prevention & control, Patient Safety, Quality Improvement
- Published
- 2017
- Full Text
- View/download PDF
45. Effect of Transient and Sustained Acute Kidney Injury on Readmissions in Acute Decompensated Heart Failure.
- Author
-
Freda BJ, Knee AB, Braden GL, Visintainer PF, and Thakar CV
- Subjects
- Acute Disease, Acute Kidney Injury diagnosis, Acute Kidney Injury epidemiology, Aged, Creatinine blood, Female, Follow-Up Studies, Heart Failure mortality, Humans, Incidence, Kidney Function Tests, Male, Retrospective Studies, Risk Factors, Survival Rate trends, Time Factors, United States epidemiology, Acute Kidney Injury etiology, Heart Failure complications, Patient Readmission trends, Risk Assessment methods
- Abstract
Although acute kidney injury (AKI) is common in heart failure, yet the impact of the onset, timing, and duration of AKI on short-term outcomes is not well studied. AKI was defined as an increase in serum creatinine SCr of ≥0.3 mg/dl or 1.5 times relative to the admission and further categorized as transient AKI (T-AKI: SCr returning to within 10% of baseline); sustained AKI (S-AKI: those with at least 72 hours of hospital stay and did not meet T-AKI); and unknown duration AKI (U-AKI: those with less than 72 hours stay and did not meet T-AKI). Reference category was no AKI (stable or <0.3 mg/dl change in SCr). The main outcome was 30-day all-cause hospital readmission. Unadjusted and adjusted association between AKI category of interest and main outcome was represented as percent and relative risks with 95% CIs. Statistical significance was set at an alpha of 0.05. From the Cerner Health Facts sample, 14,017 of 22,059 available subjects met the eligibility criteria. Approximately, 19.2% of our sample met the primary outcome. Compared with no AKI (readmission rate of 17.7%; 95% CI 16.4% to 18.9%), the adjusted rate of readmission was highest in patients with S-AKI (22.8%, 95% CI 20.8% to 24.8%; p <0.001), followed by 20.2% (95% CI 17.5% to 22.8%; p = 0.05) in T-AKI patients. Compared with no AKI, the adjusted relative risk of 30-day readmission was 1.29 (95% CI 1.17 to 1.42), 1.14 (95% CI 1.00 to 1.31), and 1.12 (95% CI, 1.01 to 1.26) in S-AKI, T-AKI, and U-AKI, respectively. In conclusion, both sustained AKI and patients with transient elevation still remain at a higher risk of readmission within 30 days. Future studies should focus on examining process-of-care after discharge in patients with different patterns of AKI., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
46. Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.
- Author
-
Abu Jawdeh BG, Leonard AC, Sharma Y, Katipally S, Shields AR, Alloway RR, Woodle ES, and Thakar CV
- Abstract
Background: Contrast-induced nephropathy (CIN) in native kidneys is associated with a significant increase in mortality and morbidity. Data regarding CIN in renal allografts are limited, however. We retrospectively studied CIN in renal allografts at our institution: its incidence, risk factors, and effect on long-term outcomes including allograft loss and death., Methods: One hundred thirty-five renal transplant recipients undergoing 161 contrast-enhanced computed tomography (CT) scans or coronary angiograms (Cath) between years 2000 and 2014 were identified. Contrast agents were iso- or low osmolar. CIN was defined as a rise in serum creatinine (SCr) by >0.3 mg/dl or 25% from baseline within 4 days of contrast exposure. After excluding 85 contrast exposures where patients had no SCr within 4 days of contrast administration, 76 exposures (CT: n = 45; Cath: n = 31) in 50 eligible patients were analyzed. Risk factors assessed included demographics, comorbid conditions, type/volume of contrast agent used, IV fluids, N -acetylcysteine administration, and calcineurin inhibitor use. Bivariate and multivariable analyses were used to assess the risk of CIN., Results: Incidence of CIN was 13% following both, CT (6 out of 45) and Cath (4 out of 31). Significant bivariate predictors of CIN were IV fluid administration ( p = 0.05), lower hemoglobin ( p = 0.03), and lower albumin ( p = 0.02). In a multivariable model, CIN was predicted by N -acetylcysteine ( p = 0.03) and lower hemoglobin ( p = 0.01). Calcineurin inhibitor use was not associated with CIN. At last follow-up, CIN did not affect allograft or patient survival., Conclusion: CIN is common in kidney transplant recipients, and there is room for quality improvement with regards to careful renal function monitoring post-contrast exposure. In our study, N -acetylcysteine exposure and lower hemoglobin were associated with CIN. Calcineurin inhibitor use was not associated with CIN. Our sample size is small, however, and larger prospective studies of CIN in renal allografts are needed.
- Published
- 2017
- Full Text
- View/download PDF
47. Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies.
- Author
-
Thakar CV
- Subjects
- Humans, Risk Factors, Acute Kidney Injury, Kidney Failure, Chronic
- Published
- 2017
- Full Text
- View/download PDF
48. Stratification and Risk Reduction of Perioperative Acute Kidney Injury.
- Author
-
Ishag S and Thakar CV
- Subjects
- Acute Kidney Injury complications, Acute Kidney Injury epidemiology, Humans, Intraoperative Complications prevention & control, Postoperative Complications prevention & control, Preoperative Period, Acute Kidney Injury prevention & control, Risk Assessment methods, Risk Reduction Behavior
- Abstract
Perioperative acute kidney injury (AKI) is associated with an increased morbidity and mortality. The incidence of AKI varies depending on preoperative risk factors and the surgical setting. Preoperative risk stratification is critical for informed consent and perioperative planning. Perioperative renal protection strategies are potentially invaluable in the prevention of AKI. Current advances in the development of biomarkers may offer the opportunity for early diagnosis and the implementation of therapeutic strategies. Increased awareness and concerted efforts by all perioperative physicians are needed to provide an improved outcome for surgical patients., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
49. Incidence, Risk Factors, and Outcome Trends of Acute Kidney Injury in Elective Total Hip and Knee Arthroplasty.
- Author
-
Nadkarni GN, Patel AA, Ahuja Y, Annapureddy N, Agarwal SK, Simoes PK, Konstantinidis I, Kamat S, Archdeacon M, and Thakar CV
- Subjects
- Acute Kidney Injury etiology, Adolescent, Adult, Aged, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Knee adverse effects, Comorbidity, Databases, Factual, Elective Surgical Procedures adverse effects, Female, Humans, Incidence, Male, Middle Aged, Risk Factors, Treatment Outcome, United States epidemiology, Young Adult, Acute Kidney Injury epidemiology, Arthroplasty, Replacement, Hip statistics & numerical data, Arthroplasty, Replacement, Knee statistics & numerical data, Elective Surgical Procedures statistics & numerical data
- Abstract
Over the past decade, there has been a marked increase in the number of primary and revision total hip and knee arthroplasties performed in the United States. Acute kidney injury (AKI) is a common complication of these procedures; however, little is known about its epidemiology in the elective arthroplasty population. We conducted a study to determine the incidence, risk factors, and outcomes of AKI after elective joint arthroplasty. Drawing on the Nationwide Inpatient Sample database, we found that the proportion of hospitalizations complicated by AKI increased rapidly from 0.5% in 2002 to 1.8% to 1.9% in 2012. Multivariate analysis revealed that the key risk factors for AKI were chronic kidney disease and the postoperative events of sepsis, acute myocardial infarction, and blood transfusion. Moreover, codiagnosis with chronic kidney disease increased the risk for AKI associated with all 3 postoperative events. After adjusting for confounders, we found an association between AKI and a significantly increased risk for in-hospital mortality and discharge to long-term facilities. AKI serves as an important quality indicator in elective hip and knee surgeries. With elective arthroplasties expected to rise, carefully planned approach to interdisciplinary perioperative care is essential to reduce both the risk and consequences of AKI.
- Published
- 2016
50. Dialysis Requiring Acute Kidney Injury in Acute Cerebrovascular Accident Hospitalizations.
- Author
-
Nadkarni GN, Patel AA, Konstantinidis I, Mahajan A, Agarwal SK, Kamat S, Annapureddy N, Benjo A, and Thakar CV
- Subjects
- Acute Kidney Injury therapy, Aged, Atrial Fibrillation epidemiology, Brain Ischemia complications, Cerebral Hemorrhage complications, Databases, Factual, Female, Humans, Hypertension epidemiology, Incidence, Long-Term Care statistics & numerical data, Male, Middle Aged, Odds Ratio, Renal Dialysis, Renal Insufficiency, Chronic epidemiology, Retrospective Studies, Risk Factors, Sepsis epidemiology, Severity of Illness Index, Stroke etiology, United States epidemiology, Acute Kidney Injury epidemiology, Brain Ischemia epidemiology, Cerebral Hemorrhage epidemiology, Hospital Mortality, Hospitalization, Patient Discharge statistics & numerical data, Stroke epidemiology
- Abstract
Background and Purpose: The epidemiology of dialysis requiring acute kidney injury (AKI-D) in acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH) admissions is poorly understood with previous studies being from a single center or year., Methods: We used the Nationwide Inpatient Sample to evaluate the yearly incidence trends of AKI-D in hospitalizations with AIS and ICH from 2002 to 2011. We also evaluated the trend of impact of AKI-D on in-hospital mortality and adverse discharge using adjusted odds ratios (aOR) after adjusting for demographics and comorbidity indices., Results: We extracted a total of 3,937,928 and 696,754 hospitalizations with AIS and ICH, respectively. AKI-D occurred in 1.5 and 3.5 per 1000 in AIS and ICH admissions, respectively. Incidence of admissions complicated by AKI-D doubled from 0.9/1000 to 1.7/1000 in AIS and from 2.1/1000 to 4.3/1000 in ICH admissions. In AIS admissions, AKI-D was associated with 30% higher odds of mortality (aOR, 1.30; 95% confidence interval, 1.12-1.48; P<0.001) and 18% higher odds of adverse discharge (aOR, 1.18; 95% confidence interval, 1.02-1.37; P<0.001). Similarly, in ICH admissions, AKI-D was associated with twice the odds of mortality (aOR, 1.95; 95% confidence interval, 1.61-2.36; P<0.01) and 74% higher odds of adverse discharge (aOR, 1.74; 95% confidence interval, 1.34-2.24; P<0.01). Attributable risk percent of mortality was high with AKI-D (98%-99%) and did not change significantly over the study period., Conclusions: Incidence of AKI-D complicating hospitalizations with cerebrovascular accident continues to grow and is associated with increased mortality and adverse discharge. This highlights the need for early diagnosis, better risk stratification, and preparedness for need for complex long-term care in this vulnerable population., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.